GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bionime 4737.TW · TWD

Health Care · Taiwan Stock Exchange · 🇹🇼 Taiwan

Compare

57.30

+2.69%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 1.84bn

FY2016FY2025

Net income

−TWD 180.3m

FY2016FY2025

Free cash flow

TWD 206.4m

FY2016FY2025

Shareholders' equity

TWD 1.75bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 1.84bnTWD 1.93bnTWD 1.76bnTWD 2.21bnTWD 1.85bnTWD 1.67bnTWD 2.17bnTWD 2.01bnTWD 1.82bnTWD 1.74bn
Gross profitTWD 627.8mTWD 768.4mTWD 715.6mTWD 1.00bnTWD 783.1mTWD 749.1mTWD 948.4mTWD 917.0mTWD 795.8mTWD 770.5m
Research and developmentTWD 354.8mTWD 322.3mTWD 242.3mTWD 202.0mTWD 187.9mTWD 247.9mTWD 255.1mTWD 201.2mTWD 160.0mTWD 140.4m
Operating income−TWD 197.4m−TWD 128.4mTWD 16.4mTWD 117.1mTWD 93.6mTWD 75.9mTWD 176.5mTWD 239.3mTWD 248.4mTWD 258.4m
Net income−TWD 180.3m−TWD 127.2mTWD 6.2mTWD 91.0mTWD 87.4mTWD 62.4mTWD 106.3mTWD 128.0mTWD 149.6mTWD 178.8m
Diluted earnings per share-2.65-1.900.091.341.310.951.662.032.372.58

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 5.70bnTWD 5.78bnTWD 5.30bnTWD 4.98bnTWD 4.56bnTWD 4.49bnTWD 4.40bnTWD 4.59bnTWD 4.37bnTWD 4.65bn
Cash and short-term investmentsTWD 485.0mTWD 382.6mTWD 449.2mTWD 277.9mTWD 312.9mTWD 399.3mTWD 382.0mTWD 472.2mTWD 486.6mTWD 988.9m
Total liabilitiesTWD 3.95bnTWD 3.89bnTWD 3.31bnTWD 2.90bnTWD 2.49bnTWD 2.41bnTWD 2.36bnTWD 2.60bnTWD 2.30bnTWD 2.06bn
DebtTWD 3.06bnTWD 3.17bnTWD 2.82bnTWD 2.27bnTWD 2.03bnTWD 2.01bnTWD 1.85bnTWD 2.12bnTWD 1.86bnTWD 1.56bn
Shareholders' equityTWD 1.75bnTWD 1.88bnTWD 1.99bnTWD 2.07bnTWD 2.07bnTWD 2.07bnTWD 2.04bnTWD 1.99bnTWD 2.08bnTWD 2.59bn
Shares outstanding68m67m67m68m67m65m64m63m63m69m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 494.8mTWD 19.5mTWD 203.4mTWD 142.3mTWD 269.7mTWD 217.6mTWD 405.6mTWD 121.9mTWD 29.6mTWD 457.8m
Capital spending−TWD 288.4m−TWD 332.8m−TWD 441.4m−TWD 312.9m−TWD 284.6m−TWD 296.4m−TWD 138.1m−TWD 168.8m−TWD 123.1m−TWD 36.8m
Free cash flowTWD 206.4m−TWD 313.3m−TWD 238.0m−TWD 170.6m−TWD 14.8m−TWD 78.8mTWD 267.5m−TWD 46.9m−TWD 93.5mTWD 421.0m
Dividends paid—−TWD 122.0m−TWD 127.7m−TWD 121.2m−TWD 124.3m−TWD 118.7m−TWD 114.9m−TWD 237.8m−TWD 241.1m−TWD 126.9m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 426.6mTWD 405.3mTWD 427.0mTWD 458.5mTWD 471.7mTWD 481.4mTWD 502.2mTWD 488.3m
Gross profitTWD 159.0mTWD 107.3mTWD 168.9mTWD 126.0mTWD 152.7mTWD 180.2mTWD 182.7mTWD 178.3m
Operating income−TWD 52.5m−TWD 88.5m−TWD 113.8m−TWD 77.9m−TWD 8.6m−TWD 20.8m−TWD 34.1m−TWD 55.2m
Net income−TWD 53.4m−TWD 79.9m−TWD 91.5m−TWD 60.5m−TWD 14.8m−TWD 12.6m−TWD 32.5m−TWD 53.8m
Diluted earnings per share-0.68-1.02-1.35-0.89-0.22-0.19-0.48-0.80
Cash from operations−TWD 93.0mTWD 9.0mTWD 66.0mTWD 142.0mTWD 133.0mTWD 152.0m−TWD 140.0mTWD 143.0m
Capital spending−TWD 5.0m−TWD 24.0m−TWD 55.0m−TWD 92.0m−TWD 72.0m−TWD 67.0m−TWD 83.0m−TWD 86.0m
Free cash flow−TWD 98.0m−TWD 15.0mTWD 11.0mTWD 50.0mTWD 61.0mTWD 85.0m−TWD 223.0mTWD 57.0m
Total assetsTWD 5.65bnTWD 5.65bnTWD 5.70bnTWD 5.58bnTWD 5.67bnTWD 5.71bnTWD 5.78bnTWD 5.55bn
Cash and short-term investmentsTWD 444.8mTWD 449.4mTWD 485.0mTWD 366.6mTWD 375.0mTWD 404.4mTWD 382.6mTWD 387.6m
DebtTWD 1.16bnTWD 2.54bnTWD 3.06bnTWD 2.96bnTWD 3.03bnTWD 3.10bnTWD 3.17bnTWD 2.95bn
Shareholders' equityTWD 2.10bnTWD 2.20bnTWD 1.75bnTWD 1.85bnTWD 1.88bnTWD 1.88bnTWD 1.88bnTWD 1.84bn

Financial ratios

Data as of 17 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin34.1%39.7%40.8%45.4%42.3%44.9%
Operating margin-10.7%-6.4%0.9%5.3%5.1%3.2%
Net margin-9.8%-6.6%0.4%4.1%4.7%3.7%
Return on equity-10.3%-6.8%0.3%4.4%4.2%3.0%
Return on assets-3.2%-2.2%0.1%1.8%1.9%1.4%
Free cash flow yield12.9%0.5%5.4%3.7%7.1%5.9%
Revenue growth-4.9%10.1%-20.6%19.5%10.9%-23.2%
Earnings growth41.7%-2148.9%-93.2%4.1%40.0%-41.2%
Current ratio0.75x0.77x1.01x1.16x1.05x1.17x
Debt to equity1.75x1.68x1.41x1.09x0.98x0.97x
Equity ratio30.6%32.5%37.5%41.6%45.3%46.1%
Interest coverage-3.04x-1.99x0.34x3.82x4.92x2.44x
R&D as a share of sales19.3%16.7%13.8%9.1%10.2%14.9%
Buybacks as a share of market value-1.3%-0.3%1.4%-1.4%-2.3%-2.4%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-6.0%2.0%1.3%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin37.0%40.3%41.3%42.6%
Operating margin-8.6%-2.5%-0.2%5.3%
Net margin-8.2%-2.7%-0.5%2.9%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-22.4-34.1—57.558.071.148.423.623.421.7
Price to sales2.22.22.92.42.72.72.41.51.92.2

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 29 Jul 2024.

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Paid in the year1.8011.8911.801.8571.7941.7993.7282.49
  • 1099-for-1000 split · 8 Sept 2025
  • 11-for-10 split · 22 Jul 2011

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.